Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Filings indexed 873 across all filing types
Latest filing 2023-04-11 Regulatory Filings
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Episurf Medical provides update on establishment of US commercial organisation
Regulatory Filings Classification · 1% confidence The document is a short announcement titled "Episurf Medical provides update on establishment of US commercial organisation." It details progress on building a distributor network and gaining surgeon interest for a product in the US market. It is not a full financial report (10-K, IR, ER), nor is it a specific regulatory filing like a Director's Dealing or Capital Change. It is an update on business operations and strategy execution, which is often categorized as general corporate information. Given the options, it is a general business update that doesn't fit the specific financial or governance codes. Since it is an update on business progress rather than a formal regulatory disclosure of a specific event (like M&A, dividend, or management change), and it is not a transcript or presentation, the most appropriate general category is Regulatory Filings (RNS) as a fallback for miscellaneous corporate news, although it strongly resembles an Investor Relations update. However, looking closely at the definitions, it is a general business update that doesn't fit the specific categories like DIV, CAP, MANG, or DIRS. It is not an Earnings Release (ER) or Interim Report (IR). Since it is a specific operational update, and not a formal announcement of a report (RPA), RNS is the best fit as a general corporate announcement.
2023-04-11 English
Annual Report (ESEF) 2022
Annual Report (ESEF) Classification · 1% confidence FY 2022
2023-04-04 Swedish
Annual Report (ESEF) 2022
Annual Report (ESEF) Classification · 1% confidence FY 2022
2023-04-04 Swedish
Nytt patentbeviljande i Kanada för Episurf Medical
Regulatory Filings Classification · 1% confidence The document is a short press release announcing that the Canadian Patent Office (CIPO) intends to grant a new patent to Episurf Medical for a system related to 3D-based assessment of joint injuries. It includes quotes from management and contact information. It is not a comprehensive financial report (like 10-K or IR), a management discussion (MDA), or an earnings release (ER). It is a specific announcement regarding intellectual property/patents. Since there is no specific code for 'Patent Grant Announcement', and it is a regulatory/official announcement concerning the company's assets/operations, the most appropriate general category is 'Regulatory Filings' (RNS), as it is a formal disclosure required under market abuse regulations (mentioned at the end: "Denna information är sådan information som Episurf Medical AB är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning").
2023-04-03 Swedish
New Canadian patent approval for Episurf Medical
Regulatory Filings Classification · 1% confidence The document announces the receipt of a 'Notice of Allowance' from the Canadian Intellectual Property Office (CIPO) for a new patent related to medical imaging and surgical preplanning. This is a specific announcement regarding intellectual property rights and regulatory approval in a specific jurisdiction. It is not an Annual Report (10-K), Earnings Release (ER), or a general regulatory filing (RNS). The most fitting category is 'Intellectual Property' (IP), as it directly concerns a patent approval.
2023-04-03 English
Notice of Annual General Meeting of Episurf Medical AB (publ)
AGM Information Classification · 1% confidence The document is explicitly titled "Notice of Annual General Meeting of Episurf Medical AB (publ)" and details the date, time, location, and procedures for shareholders to exercise their voting rights, including in-person attendance, proxy voting, and postal voting. It also contains the proposed agenda for the meeting, which includes resolutions on board elections, remuneration, and incentive programs. This content directly aligns with the purpose of materials distributed for an Annual General Meeting (AGM). Although it contains proposals that might be found in a Proxy Statement (DEF 14A or PSI), the primary context is the formal notice and logistics for the AGM itself. Therefore, the most appropriate classification is AGM-R (AGM Information).
2023-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.